Fabrice Chouraqui
Patrimonio netto: 221 838 $ in data 30/06/2026
Patrimonio netto: 221 838 $ in data 30/06/2026
Fabrice Chouraqui is currently Chief Executive Officer & Executive Director at Pharming Group NV since 2025 and serves as an Independent Member on the Governors Board at Orano Med SAS. Former roles include Chief Executive Officer & Director at Cellarity Inc. and President at Novartis Pharmaceuticals Corp.
from 2016 to 2019.
Education includes an MBA from INSEAD and graduate and doctorate degrees from Universite Paris Cite.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
PHARMING GROUP NV 0,02% | 31/03/2026 | 161.425 ( 0,02% ) | 221 838 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PHARMING GROUP N.V. | Amministratore Delegato | 04/03/2025 |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Presidente | 01/01/2019 |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Amministratore Delegato | 12/05/2025 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale